A systematic review of factors affecting medication adherence among patients with osteoporosis

CT Yeam, S Chia, HCC Tan, YH Kwan, W Fong… - Osteoporosis …, 2018 - Springer
The aim of this review was to identify factors that influence patients' adherence to anti-
osteoporotic therapy. Factors identified that were associated with poorer medication …

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis

P Kothawala, E Badamgarav, S Ryu, RM Miller… - Mayo Clinic …, 2007 - Elsevier
OBJECTIVE To quantify the adherence of patients to drug therapy for osteoporosis in real-
world settings via a systematic review and meta-analysis of observational studies …

Comparing adherence and persistence across 6 chronic medication classes

J Yeaw, JS Benner, JG Walt, S Sian… - Journal of Managed Care …, 2009 - jmcp.org
 BACKGROUND: The National Quality Forum recently endorsed the proportion of days
covered (PDC) a measure of medication adherence as an indicator of quality in drug therapy …

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

DL Kendler, C Roux, CL Benhamou… - Journal of bone and …, 2010 - academic.oup.com
Patients treated with bisphosphonates for osteoporosis may discontinue or require a switch
to other therapies. Denosumab binds to RANKL and is a potent inhibitor of bone resorption …

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review

F Fatoye, P Smith, T Gebrye, G Yeowell - BMJ open, 2019 - bmjopen.bmj.com
Objectives This study examined patient adherence and persistence to oral bisphosphonates
for the treatment of osteoporosis in real-world settings. Methods A systematic review was …

Medication adherence in healthy elders: small cognitive changes make a big difference

TL Hayes, N Larimer, A Adami… - Journal of aging and …, 2009 - journals.sagepub.com
Objective: This was a cross-sectional study of the ability of independently living healthy
elders to follow a medication regimen. Participants were divided into a group with High …

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial

N Binkley, M Bolognese… - Journal of bone and …, 2012 - academic.oup.com
Abstract The Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) study was a
randomized, double‐blind, double‐dummy, active‐and placebo‐controlled, multiple‐dose …

The effects of exercise and physical activity participation on bone mass and geometry in postmenopausal women: a systematic review of pQCT studies

CJ Hamilton, VJD Swan, SA Jamal - Osteoporosis international, 2010 - Springer
The cumulative risk of fracture for a postmenopausal woman over the age of 50 can reach
up to 60%. Exercise has the potential to modify fracture risk in postmenopausal women …

[HTML][HTML] Prunes preserve hip bone mineral density in a 12-month randomized controlled trial in postmenopausal women: the Prune Study

MJ De Souza, NCA Strock, NI Williams, H Lee… - The American Journal of …, 2022 - Elsevier
Background Dietary consumption of prunes has favorable impacts on bone health, but more
research is necessary to improve upon study designs and refine our understandings …

Adherence to chronic medication in older populations: application of a common protocol among three European cohorts

E Menditto, C Cahir… - Patient preference …, 2018 - Taylor & Francis
Purpose The purpose of this study was to evaluate and compare medication adherence to
chronic therapies in older populations across different regions in Europe. Methods This …